Works matching DE "GLAXOSMITHKLINE"
Results: 900
The role of scientific societies in the decision-making process to recommend new vaccines: the example of rotavirus in Europe.
- Published in:
- Journal of Public Health: From Theory to Practice (2198-1833), 2008, v. 16, n. 4, p. 287, doi. 10.1007/s10389-008-0205-x
- By:
- Publication type:
- Article
Prevention of influenza by vaccination.
- Published in:
- Practice Nursing, 2009, v. 20, n. 11, p. 548, doi. 10.12968/pnur.2009.20.11.45042
- By:
- Publication type:
- Article
Pre-Quit Lozenges.
- Published in:
- 2009
- Publication type:
- Product Review
The Glaxo Canada Tax Case: A Better Pill.
- Published in:
- Tax Executive, 2010, v. 62, n. 5, p. 293
- By:
- Publication type:
- Article
The Glaxo Canada Tax Case: A Bitter Pill.
- Published in:
- Tax Executive, 2008, v. 60, n. 4, p. 269
- By:
- Publication type:
- Article
Domestic Institutions and Market Pressures as Drivers of Corporate Social Responsibility: Company Initiatives in Denmark and the UK.
- Published in:
- Political Studies, 2015, v. 63, n. 1, p. 181, doi. 10.1111/1467-9248.12092
- By:
- Publication type:
- Article
Twelve Minutes with a Biochemistry Engineer.
- Published in:
- 2010
- Publication type:
- Interview
PRODUCT REPORT.
- Published in:
- 2014
- Publication type:
- Product Review
HPV 16/18 PROPHYLACTIC CERVICAL CANCER VACCINE: DEVELOPMENT UPDATE.
- Published in:
- Infectious Diseases in Obstetrics & Gynecology, 2006, v. 2006, p. 13
- By:
- Publication type:
- Article
Serious Doubts on Safety and Efficacy of CCR5 Antagonists.
- Published in:
- Infection, 2006, v. 34, n. 2, p. 110, doi. 10.1007/s15010-006-6206-1
- By:
- Publication type:
- Article
Differences in HPV-specific antibody Fc-effector functions following Gardasil® and Cervarix® vaccination.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00628-8
- By:
- Publication type:
- Article
ISSX Corporate Supporters.
- Published in:
- Drug Metabolism Reviews, 2010, v. 42, p. vii, doi. 10.3109/03602532.2010.506068
- Publication type:
- Article
ISSX Corporate Supporters.
- Published in:
- Drug Metabolism Reviews, 2008, v. 40, p. 6, doi. 10.1080/03602530802309916
- Publication type:
- Article
For Cancers Caused by HPV, Two Vaccines Were Just the Beginning.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2011, v. 103, n. 5, p. 360, doi. 10.1093/jnci/djr053
- By:
- Publication type:
- Article
Coming Soon: Cervical Cancer Vaccines, and an Array of Public Health Issues.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2006, v. 98, n. 7, p. 432, doi. 10.1093/jnci/djj143
- By:
- Publication type:
- Article
Two HPV Vaccines Yielding Similar Success.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2005, v. 97, n. 14, p. 1030, doi. 10.1093/jnci/dji227
- By:
- Publication type:
- Article
Towards discovery of new leishmanicidal scaffolds able to inhibit Leishmania GSK-3.
- Published in:
- Journal of Enzyme Inhibition & Medicinal Chemistry, 2020, v. 35, n. 1, p. 199, doi. 10.1080/14756366.2019.1693704
- By:
- Publication type:
- Article
Follow-up interviews from The Salford Lung Study (COPD) and analyses per treatment and exacerbations.
- Published in:
- NPJ Primary Care Respiratory Medicine, 2019, v. 29, n. 1, p. N.PAG, doi. 10.1038/s41533-019-0123-0
- By:
- Publication type:
- Article
Belimumab for Treating Active Autoantibody-Positive Systemic Lupus Erythematosus: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Mepolizumab for Treating Severe Eosinophilic Asthma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Eltrombopag for the Treatment of Chronic Immune or Idiopathic Thrombocytopenic Purpura: A NICE Single Technology Appraisal.
- Published in:
- PharmacoEconomics, 2012, v. 30, n. 6, p. 483, doi. 10.2165/11591550-000000000-00000
- By:
- Publication type:
- Article
Timing, Trust and Transparency:: Wage Restructuring at Glaxosmithkline.
- Published in:
- Asian Case Research Journal, 2006, v. 10, n. 2, p. 249, doi. 10.1142/S0218927506000788
- By:
- Publication type:
- Article
FDA Eases Restrictions on the Glucose-Lowering Drug Rosiglitazone.
- Published in:
- JAMA: Journal of the American Medical Association, 2013, v. 310, n. 24, p. 2604, doi. 10.1001/jama.2013.284788
- By:
- Publication type:
- Article
Race Is On for Effective Dengue Vaccine.
- Published in:
- JAMA: Journal of the American Medical Association, 2010, v. 304, n. 13, p. 1430, doi. 10.1001/jama.2010.1386
- By:
- Publication type:
- Article
Addition of Severe Combined Immunodeficiency as a Contraindication for Administration of Rotavirus Vaccine.
- Published in:
- JAMA: Journal of the American Medical Association, 2010, v. 304, n. 10, p. 1064
- Publication type:
- Article
FDA Licensure of Bivalent Human Papillomavirus Vaccine (HPV2r Cervarix) for Use in Females and Updated HPVVaccination Recommendations From the Advisory Committee on Immunization Practices (ACIP).
- Published in:
- JAMA: Journal of the American Medical Association, 2010, v. 304, n. 6, p. 632
- Publication type:
- Article
Critics Press FDA to Act on Evidence of Rosiglitazone's Cardiac Safety Issues.
- Published in:
- JAMA: Journal of the American Medical Association, 2010, v. 303, n. 23, p. 2341, doi. 10.1001/jama.2010.788
- By:
- Publication type:
- Article
Ensuring Integrity in Industry-Sponsored Research.
- Published in:
- 2010
- By:
- Publication type:
- Editorial
Setting the RECORD Straight.
- Published in:
- 2010
- By:
- Publication type:
- Opinion
The need for clinical trials registers: a case study in the field of addiction.
- Published in:
- 2005
- By:
- Publication type:
- Editorial
Comparative Effectiveness and Safety of Generic Versus Brand-Name Fluticasone–Salmeterol to Treat Chronic Obstructive Pulmonary Disease.
- Published in:
- Annals of Internal Medicine, 2023, v. 176, n. 8, p. 1047, doi. 10.7326/M23-0615
- By:
- Publication type:
- Article
Notable Advances in clinical oncology 2010.
- Published in:
- Journal of Chinese Clinical Medicine, 2010, v. 5, n. 12, p. 723
- Publication type:
- Article
ABSTRACTS.
- Published in:
- CME: Continuing Medical Education, 2011, v. 29, n. 10, p. 431
- By:
- Publication type:
- Article
Better decision making in drug development through adoption of formal prior elicitation.
- Published in:
- Pharmaceutical Statistics, 2018, v. 17, n. 4, p. 301, doi. 10.1002/pst.1854
- By:
- Publication type:
- Article
Preparing individual patient data from clinical trials for sharing: the GlaxoSmithKline approach.
- Published in:
- Pharmaceutical Statistics, 2014, v. 13, n. 3, p. 179, doi. 10.1002/pst.1615
- By:
- Publication type:
- Article
Pharma embraces open source models.
- Published in:
- Nature Biotechnology, 2010, v. 28, n. 7, p. 631, doi. 10.1038/nbt0710-631
- By:
- Publication type:
- Article
GSK's RNA splash.
- Published in:
- Nature Biotechnology, 2010, v. 28, n. 6, p. 539, doi. 10.1038/nbt0610-539b
- By:
- Publication type:
- Article
GSK/Sirtris compounds dogged by assay artifacts.
- Published in:
- Nature Biotechnology, 2010, v. 28, n. 3, p. 185, doi. 10.1038/nbt0310-185
- By:
- Publication type:
- Article
GSK adopts antisense.
- Published in:
- Nature Biotechnology, 2009, v. 27, n. 12, p. 1066, doi. 10.1038/nbt1209-1066b
- By:
- Publication type:
- Article
GSK hosts new biotech park.
- Published in:
- Nature Biotechnology, 2009, v. 27, n. 12, p. 1069, doi. 10.1038/nbt1209-1069c
- By:
- Publication type:
- Article
Brazil and India access pharma vaccine know-how.
- Published in:
- Nature Biotechnology, 2009, v. 27, n. 12, p. 1063, doi. 10.1038/nbt1209-1063
- By:
- Publication type:
- Article
Alnylam casts IP into pool.
- Published in:
- Nature Biotechnology, 2009, v. 27, n. 9, p. 785, doi. 10.1038/nbt0909-785b
- By:
- Publication type:
- Article
Vaccine market boosters.
- Published in:
- Nature Biotechnology, 2009, v. 27, n. 6, p. 499, doi. 10.1038/nbt0609-499
- By:
- Publication type:
- Article
FDA on warpath for Google links.
- Published in:
- Nature Biotechnology, 2009, v. 27, n. 5, p. 405, doi. 10.1038/nbt0509-405
- By:
- Publication type:
- Article
Biotech scientists bank on big pharma's biologics push.
- Published in:
- Nature Biotechnology, 2009, v. 27, n. 3, p. 293, doi. 10.1038/nbt0309-293
- By:
- Publication type:
- Article
Oslo's cancer leap.
- Published in:
- Nature Biotechnology, 2008, v. 26, n. 12, p. 1320, doi. 10.1038/nbt1208-1320a
- By:
- Publication type:
- Article
CD20 blockers eye crowded rheumatology market.
- Published in:
- Nature Biotechnology, 2008, v. 26, n. 10, p. 1053, doi. 10.1038/nbt1008-1053
- By:
- Publication type:
- Article
GSK's Harvard cash injection.
- Published in:
- Nature Biotechnology, 2008, v. 26, n. 9, p. 956, doi. 10.1038/nbt0908-956
- By:
- Publication type:
- Article
GSK slashes internal R&D.
- Published in:
- Nature Biotechnology, 2008, v. 26, n. 8, p. 840, doi. 10.1038/nbt0808-840
- By:
- Publication type:
- Article
Myriad stumbles, Wyeth closes on Alzheimer's.
- Published in:
- Nature Biotechnology, 2008, v. 26, n. 8, p. 841, doi. 10.1038/nbt0808-841
- By:
- Publication type:
- Article